Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 3229-3236, June 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yokoyama, M.
Right arrow Articles by Kataoka, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yokoyama, M.
Right arrow Articles by Kataoka, K.

Toxicity and Antitumor Activity against Solid Tumors of Micelle-forming Polymeric Anticancer Drug and Its Extremely Long Circulation in Blood

Masayuki Yokoyama1, Teruo Okano, Yasuhisa Sakurai, Hisao Ekimoto, Chieko Shibazaki and Kazunori Kataoka

Institute of Biomedical Engineering, Tokyo Women's Medical College; Kawada-cho, Shinjuku-ku, Tokyo 162 [M. Y., T. O., Y. S.] Nippon Kayaku Co., Ltd., Shimo 3-31-12, Kita-ku, Tokyo 115 [H. E., C. S.]; and Department of Materials Science and Technology and Research Institute for Biosciences, Science University of Tokyo, Yamazaki 2641, Noda-shi, Chiba 278 [K. K.], Japan

Toxicity and in vivo antitumor activity against five solid tumors (C 26, C 38, M 5076, MKN-45, MX-1) of Adriamycin (ADR)-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer {PEG-P[Asp(ADR)]} were evaluated, and its pharmacokinetic behavior in blood and biodistribution by i.v. injection were obtained. PEG-P[Asp(ADR)] was revealed to express higher antitumor activity than ADR against all the examined tumors except MKN-45. Especially against C 26, PEG-P[Asp(ADR)] expressed critical suppression of tumor growth and considerably prolonged life span of the treated mice. PEG-P[Asp(ADR)] was observed in blood at much higher concentrations with a longer half-life than ADR after the i.v. injection. PEG-P[Asp(ADR)] was known to form a micellar structure with a diameter of approximately 50 nm and a narrow distribution in phosphate-buffered saline. Therefore, the stabilized circulation of ADR residue in blood by binding to the block copolymer was considered to result from the micellar structure which possesses the hydrated outer shell composed of the poly(ethylene glycol) chains.

1 To whom requests for reprints should be addressed.

Received 12/26/90. Accepted 3/28/91.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. C. Lee, E. R. Gillies, M. E. Fox, S. J. Guillaudeu, J. M. J. Frechet, E. E. Dy, and F. C. Szoka
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas
PNAS, November 7, 2006; 103(45): 16649 - 16654.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Koizumi, M. Kitagawa, T. Negishi, T. Onda, S.-i. Matsumoto, T. Hamaguchi, and Y. Matsumura
Novel SN-38-Incorporating Polymeric Micelles, NK012, Eradicate Vascular Endothelial Growth Factor-Secreting Bulky Tumors.
Cancer Res., October 15, 2006; 66(20): 10048 - 10056.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Uwatoku, H. Shimokawa, K. Abe, Y. Matsumoto, T. Hattori, K. Oi, T. Matsuda, K. Kataoka, and A. Takeshita
Application of Nanoparticle Technology for the Prevention of Restenosis After Balloon Injury in Rats
Circ. Res., April 18, 2003; 92 (7): e62 - e69.
[Abstract] [Full Text] [PDF]


Home page
Journal of Bioactive and Compatible PolymersHome page
K. Hoste, E. Schacht, and B. Rihova
Synthesis and Biological Evaluation of Peg-Substituted Macromolecular Prodrugs of Mitomycin C
Journal of Bioactive and Compatible Polymers, March 1, 2002; 17(2): 123 - 138.
[Abstract] [PDF]


Home page
Journal of Bioactive and Compatible PolymersHome page
J. Bariyanga
Synthesis, Characterization and Biodegradability of Poly(Ethylene Glycol)-Bound Molecule Platinum Complexcontaining Ferrocenyl Moiety Using MALDI Time-of-Flight Mass Spectrometry
Journal of Bioactive and Compatible Polymers, January 1, 2002; 17(1): 37 - 50.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
S. M. Moghimi, A. C. Hunter, and J. C. Murray
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Pharmacol. Rev., June 1, 2001; 53(2): 283 - 318.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Kamada, Y. Tsutsumi, Y. Yamamoto, T. Kihira, Y. Kaneda, Y. Mu, H. Kodaira, S.-i. Tsunoda, S. Nakagawa, and T. Mayumi
Antitumor Activity of Tumor Necrosis Factor-{{alpha}} Conjugated with Polyvinylpyrrolidone on Solid Tumors in Mice
Cancer Res., November 1, 2000; 60(22): 6416 - 6420.
[Abstract] [Full Text]


Home page
Journal of Bioactive and Compatible PolymersHome page
A. De Marre, K. Hoste, D. Bruneel, E. Schacht, and F. De Schryver
Synthesis, Characterization, and in Vitro Biodegradation of Poly(Ethylene Glycol) Modified Poly[5N-(2-Hydroxyethyl-L-Glutamine]
Journal of Bioactive and Compatible Polymers, April 1, 1996; 11(2): 85 - 99.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.